SELLAS Life Sciences (SLS) Total Liabilities (2019 - 2024)
Historic Total Liabilities for SELLAS Life Sciences (SLS) over the last 9 years, with Q3 2024 value amounting to $10.6 million.
- SELLAS Life Sciences' Total Liabilities fell 1091.24% to $10.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was $10.6 million, marking a year-over-year decrease of 1091.24%. This contributed to the annual value of $14.2 million for FY2023, which is 1178.85% down from last year.
- Latest data reveals that SELLAS Life Sciences reported Total Liabilities of $10.6 million as of Q3 2024, which was down 1091.24% from $12.2 million recorded in Q2 2024.
- SELLAS Life Sciences' Total Liabilities' 5-year high stood at $18.1 million during Q4 2020, with a 5-year trough of $5.9 million in Q4 2021.
- Over the past 5 years, SELLAS Life Sciences' median Total Liabilities value was $12.2 million (recorded in 2024), while the average stood at $12.7 million.
- In the last 5 years, SELLAS Life Sciences' Total Liabilities tumbled by 6722.69% in 2021 and then surged by 17145.75% in 2022.
- SELLAS Life Sciences' Total Liabilities (Quarter) stood at $18.1 million in 2020, then tumbled by 67.23% to $5.9 million in 2021, then surged by 171.46% to $16.1 million in 2022, then fell by 11.79% to $14.2 million in 2023, then decreased by 25.23% to $10.6 million in 2024.
- Its last three reported values are $10.6 million in Q3 2024, $12.2 million for Q2 2024, and $14.8 million during Q1 2024.